An in vivo system was used to study the effects of vitamin E, selenium (in the form of sodium selenite) and steroidal antiinflammatory drugs on hepatic, lysosomal membranes. After administering these compounds for 3 days to rats, hepatic lysosomes were isolated and subjected to thermally in duced labi liza tion by incubating lysosomes in 0.25 M sucrose at 45Â°for 90 min utes. Release of two enzymes, acid phosphatase and /3-glucuronidase, was used as an index of labilization. Vitamin E stabilized lysosomes in dosages of 0.100 to 3.9 units/kilogram and produced maximal stabilization at a daily dosage of 0.100 unit/kilogram. Selenium was effective in stabilizing lysosomes at a dose level of 2.0 /Â¿g/kg,only. Low dosages of selenium (0.5 Mg/kg) potentiated vitamin E (0.039 unit/kg), but higher dosage (50 Mg/kg) antagonized vitamin E (3.4 units/kg). Results suggest that the interaction of vitamin E and selenium in attenuating animal diseases caused by deficiencies of vitamin E or selenium may be due to their mutual potentiation in stabilizing lysosomal membranes, pro vided that they are administered in the same ratio and at the low levels found herein to cause such potentiation.
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The mode of interaction of selenium and vitamin E in preventing experimentally in duced diseases in animals is unknown, but the activities of both substances seem to be closely associated (1) (2) (3) (4) (5) (6) . Thus, rats fed a necrogenic diet develop hepatonecrotic lesions characterized by progressive degen eration of hepatocellular plasma mem branes (1) ; dietary supplements of vita min E or selenium prevent such necrosis ( 1) suggesting that either agent stabilizes the hepatocellular plasma membrane. Vitamin E also stabilizes erythrocyte and leucocyte membranes during storage of human blood, thereby preserving the nor mal morphology of erythrocytes and at tenuating the decrease in the number of leucocytes (7) . Degenerative changes in Duchenne's muscular dystrophy (8) , vita min E or selenium deficiencies (9â€"12)and white muscle disease (9â€"12) can be cor related to some degree with the release of lysosomal enzymes. In the former disease, enzymes are apparently released from cells of cardiac and skeletal muscles, liver cells, and erythrocytes (8) , suggesting a gener alized lability of the membranes of all of these types of cells. Thus, a general, non specific, membrane-stabilizing effect of selenium and/or vitamin E could explain their prophylactic and curative (12, 13) effects, especially if one considers that a stabilizing effect may be applicable to the membranes of endothelial cells of the microvasculature, lysosomal membranes, mitochondria! membranes, and cellular membranes of the liver, muscle, pancreas (6) and other tissue cells.
The purpose of the present investigation was to determine whether selenium and/or vitamin E have a protective effect in vivo on lysosomal membranes. This was esti mated quantitatively by administering these substances to rats for 3 days, isolat ing their hepatic lysosomes and subjecting the latter to thermal labilization (14, 15) .
MATERIALS AND METHODS

Enrichment of lysosomes. Drugs or
vehicle were administered to normal rats of the Sprague-Dawley strain (male, 175 to 250 g, 43 to 57 days old) intraperitoneally for 3 days and the animals were killed on the morning of day 4. Animals were fed a commercial stock diet3 (65 IU vitamin E/kg) ad libitum. Experiments with vita min E were carried out over a period of 2 years. Results with the two higher dose levels were repeated two or three times for confirmation of results both in this and another laboratory. 4 Results with control animals were obtained repeatedly over the 2-year period using four to eight animals per experiment. Thus animals were not fed a single supply of stock diet.
The enrichment of lysosomes and all other procedures were similar to those previously described (14, 15) . Briefly, por tions of livers from two animals (N = 1) were pooled, minced and immediately placed in ice-cold (2Â°) 0.25 M sucrose. Thus, for N = 4 in table 1, eight drugtreated rats would have been used. A 10% homogenate was prepared by grinding briefly 3 g of liver in a mortar containing ice-cold 0.25 M sucrose followed by fur ther homogenization in a motor-driven Potter-type tissue homogenizer (Teflon pestle) using three to four up and down strokes. The volume of the resulting homog enate was adjusted to 30 ml, divided into two equal portions in two graduated cylin ders and each aliquot was centrifugea (1000 X g, 4Â°,15 minutes) in two separate centrifuge tubes to remove unbroken cells and nuclear debris. The supernates from the two centrifuge tubes were recovered and centrifuged (25,000 X g, 4Â°,15 min utes) to obtain the lysosomal-rich pellets. This preparation thus contained mitochon dria. The pellet in one centrifuge tube was resuspended in ice-cold 0.25 M sucrose (15 ml) and incubated at 45Â°for 90 minutes to effect thermally induced enzyme re lease; the pellet in the other centrifuge tube was resuspended in distilled water and incubated at 22Â°for 30 minutes to obtain maximal hypotonically induced re lease of lysosomal enzymes. The pH of the resulting suspension was 6.8 due to endog enous buffer systems. Detergents such as Triton X-100 were not employed to disrupt lysosomes because in preliminary experi ments it could be demonstrated that lyso somal membranes obtained after centrifugation (25,000 X g, 4Â°,15 minutes) of hypotonically distrupted lysosomes are dis integrated by such agents, thereby releas ing membrane-bound enzymes. After incu bation, each tube was centrifuged (25,000 X g, 4Â°,15 minutes) and the supernates were assayed for released enzymes. Re leased enzyme activity was calculated by dividing the amount of enzyme activity re leased thermally by the amount released in distilled water, times 100. Percentage en zyme release of drug-treated animals was compared to that of vehicle-treated ani mals and percentage inhibition of re lease due to drug effects was calcu lated therefrom. Total enzyme activity re leased hypotonically was not decreased by treatment with any of the drugs reported herein. Selenium was administered in the form of sodium selenite.
Enzyme assays. Acid phosphatase (AP, EC 3.1.3.2) and ÃŸ-glucuronidase (BG, EC 3.2.1.31) activities were determined using modifications of methods previously de scribed (14, 15) . Briefly, the reaction mix ture for AP contained 0.5 ml of 0.09 M citrate buffer solution, pH 4.8, 0.2 ml p-nitrophenyl phosphate (10 mg/ml), 0.3 ml distilled water and 0.05 ml of lysosomal enzyme solution. Incubation was carried out at 37Â°for 30 minutes and was termi nated by the addition of 5.0 ml of 0.1 N NaOH. The absorbance (OD) of the result ing solution was measured at 420 m^using a colorimeter.5 The reaction mixture for BG contained 0.5 ml of 0.075 M phosphate buffer, pH 4.5, 0.5 ml of 0.0015 M phenolphthalein glucuronic acid, 0.2 ml distilled water, and 0.15 ml of enzyme solution. After 30 minutes' incubation at 37Â°,reac tion was terminated by addition of 5.0 ml To ascertain whether the compounds to be studied had any direct effects on lyso somal enzyme activity per se, half of the lysosome-rich fraction was suspended in distilled water to half of the usual volume (7.5 ml), incubated at 22Â°for 30 minutes and centrifuged (25,000 X g, 4Â°,15 min utes). To 1.5 ml of the resulting "free" enzyme solution, 1.5 ml of drug or sucrose solution was added, and the tubes were incubated for 90 minutes at 45Â°.Triamcinolone acetonide solutions contained a final concentration of 10"" or 10~Â» M in 0.25 M sucrose, vitamin E solutions were 7.80 or 0.78 IU/100 ml, and sodium sele nite solutions contained 16 or 1.6 /xg/100 ml selenium equivalent. A water-soluble E ( d-o-tocopheryl polyethylene glycol 1000 succinate *) was used in these in vitro studies.
RESULTS
Initial experiments were conducted to determine whether substrate concentra tions used in the enzyme assays were suf ficient for the amounts of enzymes released thermally or hypotonically. Absorbance values (used to express enzymic activity) were directly proportional to the volume (amount) of free lysosomal enzymes added; the volumes of enzyme solutions used for assaying acid phosphatase and yg-glucuronidase (0.05 ml and 0.15 ml, respectively) were located within the linear portions of these curves.
The degree of stabilization of lysosomes by vitamin E increased with increasing dosage (table 1). Maximal stabilization was attained with 0.100 unit/kilogram. Stabilization of lysosomal membranes is indicated by the attenuated release of both acid phosphatase and ÃŸ-glucuronidase. That both of these enzymes were derived from the same source is indicated by the almost identical degree of thermally in duced release, and by the almost identical degree of inhibition of release (tables 1, 2). Such results also strongly suggest a lack of interference with release of en zymes or enzyme activity per se by any mitochondria or microsomes which may have been present. Selenium at 2 /xg/kg also stabilized lysosomes, but at higher or lower dose levels this effect was not ob- served. Quantitatively similar results were obtained with two potent steroidal antiinflammatory drugs, viz. dexamethasone and triamcinolone (table 2) . Vitamin E (equivalent to 67^g/kg d-a-tocopherol) and dexamethasone (50 /Â¿g/kg) produced greater than 43% inhibition of release of acid phosphatase or ÃŸ-glucuronidase at almost identical dosage. Thus, the potency of vitamin E was almost the same as that of dexamethasone, one of the most potent glucocorticoids known. Dexamethasone (14) , vitamin E (7.8 and 0.78 IU/100 ml), and selenium (16 and 1.6 Â¿ig/100 ml in the form of sodium selenite ) had no inhibitory effect in vitro on either of the free lysosomal enzymes when incubated for 90 minutes at 45Â°in 0.25 M sucrose at concentrations higher than could have been attained in vivo in the studies re ported herein. Using low dose levels of selenium (0.5 /*g/kg) and vitamin E (0.039 unit/kg) potentiation was observed, i.e., neither agent alone at such dosage stabilized lysosomal membranes but to gether a statistically significant degree of stabilization occurred. With approximately the same ratio of these two substances, but at 100 times higher levels, augmented re lease (P < 0.05) of lysosomal enzymes was observed (table 1), viz. significant labilization. It is therefore concluded that the agents mentioned above exert a protective effect on lysosomal membranes of rat liver when such membranes are stressed therm ally, but potentiation is observed only when selenium and vitamin E are given together at low dosages.
DISCUSSION
Results demonstrate a suitable assay system for studying the effects of lysosomal-stabilizing agents in vivo on lyso somes isolated after administering such agents to rats for 3 days. Substrate con centrations selected for enzyme determina tions in this system were sufficient for the amounts of enzymes released thermally or hypotonically. As a result of prelimin ary experiments, isolated hepatic lyso somes were incubated in 0.25 M sucrose only. Exogenous buffer was not necessary since the pH of the resulting lysosomal suspension remained 6.8 due to endog enous buffer systems. Moreover, the ad ministration of drugs in vivo eliminates the need of exogenous buffering during incu bation since no drug has to be added directly, thus avoiding a possible correction factor due to direct enzyme inhibition, al though the latter should nonetheless be determined.
In the experiments reported herein ani mals received a commercial stock diet (65 lU/kg vitamin E) ad libitum. Each con sumed an average of 20 g of food per day, in agreement with data of Goyer et al. (16) , which is equivalent to 1.3 IU/rat/ day. Absorption of vitamin E, however, is quite low (17) . Goyer et al. (16) found that rat liver contains 15^g of vitamin E per gram of liver (for livers weighing 6.2 g; but only 63^g of vitamin E when total vitamin E was expressed per 100 g body weight for rats weighing about 125 g. Since their rats consumed 370 /Â¿g of vita min E per day, and the liver contained more vitamin E than other tissues as is obvious from the data above or from ex periments of Mason (17) , either the ab sorption of vitamin E is quite low or the metabolism of vitamin E is quite high. An increased intake of vitamin E may thus be expected to augment the content of vitamin E in the liver, especially if the vitamin is injected intraperitoneally. After intraperitoneal absorption, substances are carried via the portal vein to the liver wherein it is well known that a large por tion of injected drugs, and probably vita min E (17), is extracted from the blood during the first circulatory transit through the portal vein-sinusoid-hepatic vein cir cuit. Absorption of drugs after oral admin istration takes a similar course. Concen tration of vitamin E in the liver was described by Mason (17) . In that study it was shown that the liver of rats can con centrate vitamin E as much as four to fourteen times, depending upon whether there was a low or high level of intake of vitamin E. Thus, in the experiments re ported herein, one could consider the effect of vitamin E to be either a nutri tional effect7 or a pharmacologie effect. Our daily dosages of 0.039 to 3.9 lU/kg of vitamin E are also well within the range of 0.8 to 1.2 mg (1.2 to 1.8 IU) of ct-tocopherol (iv) per normal rat required to inhibit hemolysis induced by hydrogen peroxide, 24 to 48 hours after the rats re ceived vitamin E (18) . Since the selenium content of the commercial diet is not de termined by the manufacturer and there fore is unknown, it is certainly possible that the diet could have been marginally deficient in selenium. If so, the results with exogenous vitamin E or selenium must be interpreted as nutritional effects.
Inhibition of release of lysosomal en zymes by dexamethasone was observed at dose levels that are equivalent to the usual pharmacologie dosages administered to man (0.75 mg, once to three times per day). Such dose levels in a 70-kg man are 10 to 33 Â¿Â¿g/kg. Since dexamethasone is 25 times more potent than cortisol (19) , such a dosage is equivalent to 18 to 58 mg cortisol per 70-kg man. This dosage is well within the range of normal, daily secre tion of cortisol by the adrenal cortex of a normal human subject (19) . On this basis one would probably not expect a therapeu tic effect, yet dexamethasone is very effec tive in many clinical situations at this dos age; indeed, this or higher dosage causes severe side effects (19, 20) . Moreover, 5 to 10 /Â¿g/kgof dexamethasone is effective in attenuating polyarthritis in rats after oral (21) or intraperitoneal administra tion (unpublished results). At ten times higher dosages rats do not survive. This dosage is also slightly less than that re ported herein to diminish the thermally induced release of lysosomal enzymes. Thus the liver is probably also concentrat ing dexamethasone as it does vitamin E. There may also be a narrow margin be tween efficacy and side effects with vita min E, as noted above in rats for dexa methasone or as described by Sones and Slocumb (20) . Thus, at the 3.9 lU/kg dos age of vitamin E (table 1) release of only one of the lysosomal enzymes is signifi cantly inhibited. Still larger amounts of vitamin E (0.5 ml) have been employed to induce inflammation in air pouches on the dorsum of rats (22) .
Nutritionally, vitamin E may be con sidered by some as an antisterility factor, but from the standpoint of pharmacodynamics it seems more pertinent to describe vitamin E as a nutritional, antiflammatory factor. It thus seems more than coinci dental that either vitamin E or antiinflammatory drugs stabilize erythrocytes to hemolysis (23) (24) (25) (26) (27) induced by thermal stress or hydrogen peroxide. Likewise, it seems more than coincidental that antiinflammatory drugs stabilize capillaries or venules of the microvasculature to various agonists, thereby blocking edema and swelling as does vitamin E in preventing the increase in capillary permeability re sulting in edema and swelling associated with myocardial lesions, nutritional encephalomalacia, and exudative diathesis (17) . One of the principal metabolites of vitamin E (tocopheronolactone) consid ered by some investigators (28) to be the active metabolite of vitamin E, does possess antiinflammatory activity in phar macologie assays and also inhibits the re lease of acid phosphatase and ÃŸ-glucuronidase in vivo or in vitro (29) . Moreover, stabilization of lysosomes by vitamin E could explain prevention of dietary necrotic liver degeneration, since release of various proteolytic enzymes contained therein would be prevented. Steroidal or nonsteroidal antiinflammatory drugs have not been tested in the latter manifestation of vitamin E deficiency but may prove to be effective. Furthermore, supplementa tion of vitamin E-deficient diets with vitamine E attenuates kidney autolysis in rats and also partially protects the kidney lyso somes against increased fragility (30) .
Whether the membrane-stabilizing effect of selenium, vitamin E or steroidal antiinflammatory drugs can be reproduced on lysosomes of rat liver obtained from ani mals fed diets deficient in vitamin E or selenium is speculative. Nevertheless, the data reported herein suggest that such an effect is feasible. Buchanan-Smith et al. (10) studied the lability of hepatic lyso somes of sheep on a basal diet containing selenium, vitamin E or both. Since no con trol animals ( on normal diets or basal diets only) were included in this study (because of death in animals on basal diets only), the effects of these substances on lysosomal stability in comparison to the stabil ity of hepatic lysosomes derived from nor mal animals, or animals on a basal diet per se, are unknown. It is known, how ever, that small amounts of vitamin E added in vitro to hepatic lysosomes derived from vitamin E-deficient rats will decrease the lability of such lysosomes (11) . Since severe selenium deficiency impairs absorp tion of vitamin E (6), selenium may po tentiate vitamin E by increasing plasma levels of tocopherol. Such an interaction, however, does not fully explain the ability of either selenium or vitamin E to prevent exudative diathesis in chicks (6) or he patic necrosis in rats (1) . Low dose levels of selenium (0.5 /*g/kg) potentiated vita min E (0.039 unit/kg), whereas high dosage of selenium (50 Â¿ig/kg antago nized the stabilizing effect (table 1) of vita min E at a dosage of 3.4 units/kg, i.e., this combination results in significant (P<0.05) labilization of the lysosomal membranes. Thus, the potentiating effects of these two substances in exudative dia thesis or muscular dystrophies may be at tributed to a positive interaction in stabil izing lysosomes, since this was observed.
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